• Crescent Biopharma set inducement equity awards for three non-executive employees, granting options for 65,100 ordinary shares on June 25, 2026.
• Options carry a 10-year term with an exercise price of $16.99, set at the June 25 Nasdaq closing price.
• Vesting starts with 25% on the first anniversary of each employee’s start date, then monthly vesting of the remainder over 36 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crescent Biopharma Inc. published the original content used to generate this news brief on June 26, 2026, and is solely responsible for the information contained therein.